Home

Ideiglenes reakció Hasznos copd 5 year overall survival Árva pedál Vallási

Towards the elimination of chronic obstructive pulmonary disease: a Lancet  Commission - The Lancet
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission - The Lancet

Survival associated with chronic obstructive pulmonary disease among S |  COPD
Survival associated with chronic obstructive pulmonary disease among S | COPD

The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: |  COPD
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: | COPD

Mortality prediction in chronic obstructive pulmonary disease comparing the  GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient  data | European Respiratory Society
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data | European Respiratory Society

a) Overall survival probability categorized by Diagnoses in 1996. (b)... |  Download Scientific Diagram
a) Overall survival probability categorized by Diagnoses in 1996. (b)... | Download Scientific Diagram

Potential misclassification of causes of death from COPD | European  Respiratory Society
Potential misclassification of causes of death from COPD | European Respiratory Society

Prediction of five-year mortality after COPD diagnosis using primary care  records | PLOS ONE
Prediction of five-year mortality after COPD diagnosis using primary care records | PLOS ONE

JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth  Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide,  Population-Based Cohort Study
JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study

Kaplan-Meier plots of relapse-free survival. COPD: chronic obstructive... |  Download Scientific Diagram
Kaplan-Meier plots of relapse-free survival. COPD: chronic obstructive... | Download Scientific Diagram

Survival impact of treatment for chronic obstructive pulmonary disease in  patients with advanced non-small-cell lung cancer | Scientific Reports
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer | Scientific Reports

Survival significance of coexisting chronic obstructive pulmonary disease  in patients with early lung cancer after curative surgery - Saji - 2018 -  Thoracic Cancer - Wiley Online Library
Survival significance of coexisting chronic obstructive pulmonary disease in patients with early lung cancer after curative surgery - Saji - 2018 - Thoracic Cancer - Wiley Online Library

Severe acute exacerbations and mortality in patients with chronic  obstructive pulmonary disease | Thorax
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease | Thorax

JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth  Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide,  Population-Based Cohort Study
JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study

Cancers | Free Full-Text | Impact of Chronic Obstruction Pulmonary Disease  on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma  Undergoing Concurrent Chemoradiotherapy
Cancers | Free Full-Text | Impact of Chronic Obstruction Pulmonary Disease on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy

COPD in the general population: Prevalence, incidence and survival -  ScienceDirect
COPD in the general population: Prevalence, incidence and survival - ScienceDirect

Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to  optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery

Prediction of five-year mortality after COPD diagnosis using primary care  records | PLOS ONE
Prediction of five-year mortality after COPD diagnosis using primary care records | PLOS ONE

Chronic obstructive pulmonary disease - The Lancet
Chronic obstructive pulmonary disease - The Lancet

COPD in the general population: Prevalence, incidence and survival -  ScienceDirect
COPD in the general population: Prevalence, incidence and survival - ScienceDirect

Lung function indices for predicting mortality in COPD | European  Respiratory Society
Lung function indices for predicting mortality in COPD | European Respiratory Society

Deep radiomics-based survival prediction in patients with chronic  obstructive pulmonary disease | Scientific Reports
Deep radiomics-based survival prediction in patients with chronic obstructive pulmonary disease | Scientific Reports